Actively Recruiting

Age: 18Years +
All Genders
ID05653141

Prediction of Post-stroke Cognitive Decline and Dementia: Impact of Cognitive Reserve and Post-stroke Life Style

Led by Roza Umarova · Updated on 2026-05-06

600

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how cognitive abilities change after a first-ever anterior circulation ischemic stroke. The goal is to create a model that predicts individual differences in how stroke affects cognition over time. This observational study is conducted over six years, with patient recruitment during the first three years, and focuses on understanding the impact of cognitive reserve and lifestyle after stroke. Patients are assessed at several stages: during the acute stroke phase (within 0-10 days after stroke), the sub-acute phase (3 months post-stroke), and the chronic phase (12 months and 3 years post-stroke). At each time point, comprehensive neuropsychological tests are performed alongside evaluations of clinical and functional status. Researchers also measure factors related to cognitive reserve and the patients' physical activity after stroke. Participants undergo detailed cognitive and functional assessments at each visit, including evaluations at 3 months, 12 months, and 36 months post-stroke. The main outcomes include the number of participants experiencing delayed cognitive or functional decline at these time points. The study also tracks cognitive impairment shortly after stroke and over the following years. The research accounts for challenges like participant dropout and mortality, aiming to provide a robust understanding of post-stroke cognitive trajectories.

CONDITIONS

Brief Title

Post-stroke Cognitive Impairment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • First-ever anterior circulation ischemic stroke confirmed by routine MRI
  • Enrollment within 10 days from stroke onset
Not Eligible

You will not qualify if you...

  • History of previous stroke based on clinical imaging or medical history
  • Additional stroke in the posterior circulation
  • Conditions that prevent cognitive testing such as delirium, intubation, or reduced alertness
  • Neurological or psychiatric conditions that interfere with data interpretation, including pre-stroke dementia, schizophrenia, brain tumor, regular benzodiazepine use, or depression
  • Contraindications for MRI
  • Native language other than German, French, or Italian

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Up to 10 days from stroke onset

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Diagnostic Evaluation

Duration - 0 to 10 days post-stroke

Participants undergo comprehensive neuropsychological testing and assessments of clinical and functional status during the acute stroke phase.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 3 years post-stroke

Participants are assessed for cognitive performance, clinical status, and functional status at multiple time points post-stroke, including sub-acute and chronic phases, to track cognitive and functional changes over time.

Visits at 3 months, 12 months, and 36 months post-stroke (in-person)

Trial Site Locations

Total: 1 location

1

Department of Neurology, Inselspital, University Hospital Bern, University of Bern

Bern, Switzerland, 3010

Actively Recruiting

Loading map...

Research Team

R

Roza M. Umarova, PD Dr.

L

Laura Gallucci, MSc

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Determining Which Brain Regions Are Active During Flight Sim...

Cognitive Performance

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.

Laura Gallucci, Christoph Sperber, Andreas U Monsch...

https://pubmed.ncbi.nlm.nih.gov/39209968